Problematik von Long‑/Post-COVID in der Begutachtung
Tóm tắt
Từ khóa
Tài liệu tham khảo
AWMF S1-Leitlinie Long/ Post-COVID (Reg. Nr. 020-027). https://www.awmf.org/leitlinien/detail/ll/020-027.html. Zugegriffen: 20. Okt. 2022
AWMF-Leitlinie (Reg.Nr. 030-144) Neurologische Manifestationen bei COVID-19. https://www.awmf.org/uploads/tx_szleitlinien/030-144l_S1_Neurologische_Manifestationen_bei_COVID-19_2021-12.pdf (Erstellt: 20. Dez. 2021). Zugegriffen: 20. Okt. 2022
Townsend L et al (2020) Persistent fatigue following SARS-CoV‑2 infection is common and independent of severity of initial infection. PLoS ONE 15(11):e240784
National Institute for Health and Care Excellence (2020) COVID-19 rapid guideline: managing the long-term effects of COVID-19
Schwab K, Schwitzer E, Qadir N (2022) Postacute sequelae of COVID-19 critical illness. Crit Care Clin 38(3):455–472
Förster C, Colombo MG, Wetzel AJ, Martus P, Joos S (2022) Persisting symptoms after COVID-19. Prevalence and risk factors in a population-based cohort. Dtsch Arztebl Int 119:167–174. https://doi.org/10.3238/arztebl.m2022.0147
Nguyen NN et al (2022) Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review. Eur J Clin Microbiol Infect Dis 41(4):515–545
Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Cardoso JM, May A, Ganesh S, Davies R, Nguyen LH, Drew DA, Astley CM, Joshi AD, Merino J, Tsereteli N, Fall T, Gomez MF, Duncan EL, Menni C, Williams FMK, Franks PW, Chan AT, Wolf J, Ourselin S, Spector T, Steves C (2021) Attributes and predictors of long COVID. Nat Med 27(4):626–631. https://doi.org/10.1038/s41591-021-01292-y
Tegenthoff M, Drechsel-Schlund C, Widder BB (2021) Neurologisch-psychiatrische Begutachtung des Post-COVID-Syndroms. Nervenarzt. https://doi.org/10.1007/s00115-022-01292-4
Drechsel-Schlund C (2020) Funktionseinschränkungen bei psychischen Unfallfolgen und MdE-Bewertung – aus Sicht der gesetzlichen Unfallversicherung. Med Sachverstand 116:125–129
Dreßing H, Meyer-Lindenberg A (2021) „Long-Covid“ und „Post-Covid“ in der psychiatrischen Begutachtung. Med Sachverstand 1(17):228–234
Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, Thurow J, Wagner D, Waller C, Niesen WD, Frings L, Urbach H, Prinz M, Weiller C, Schroeter N, Meyer PT (2021) Cognitive Impairmentandaltered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 144:1263–1276
Cabanes-Martinez L, Villadniga M, Gonzlez-Rodrguez L, Araque L, Daz-Cid A, Ruz-Caracuel I, Pian H, Sänchez-Alonso S, Fanjul S, Del lamo M, Regidor I (2020) Neuromuscular involvement in COVID-19 critically ill patients. Clin Neurophysiol 131(12):2809–2816
Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, Huang E, Zuo QK (2021) The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann NY Acad Sci 1486:90–111
Dettmers C, Broscheid KC, Peters A, Hoogerbeets O, Sailer S, Wolff W, Vieten M, Jögbes M (2021) Motorische Fatigue und Fatigability bei MS. In: Penner IK (Hrsg) Fatigue bei Multipler Sklerose. Hippocampus, Bad Honnef, S 51–61
Dettmers C, Marchione S, Weimer-Jaekel A, Godde B, Joebges M (2021) Cognitive fatigability, not fatigue predicts employment status inpatients with MS three months after rehabilitation. Mult Scler Relat Disord 56:10321
Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, Svik M, Bartsch H, Tondel C, Kittang BR, Cox RJ, Langeland NN, Bergen COVID‑1 9 Research Group (2021) Long COVID in a prospective cohort of home-isolated patients. Nat Med 27:1607–1613
Bungenberg J, Humkamp K, Hohenfeld C, Rust MI, Ermis U, Dreher M, Hartmann NK, Marx G, Binkofski F, Finke C, Schulz JB, Costa AS, Reetz K (2022) Long COVID-19: Objectifying most selfreported neurological symptoms. Ann Clin Transl Neurol. https://doi.org/10.1002/acn3.51496
Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 11:16144
Brandenburg S, Woltjen M (2021) COVID-19 als Berufskrankheit oder Arbeitsunfall. Med Sachverstand 117:113–118
Struve N, Maier N (2021) Handlungsempfehlung Fallsteuerung COVID-19-Krankheitsfolgen, Handlungsempfehlung Fallsteuerung COVID-19-Krankheitsfolgen Stand 05/2021. Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege (BGW)
https://intranet.bgw-online.de/SharedDocs/Downloads/DE/Reha-Handbuch/Berufskrankheiten/H/Handlungsempfehlung_Coronavirus_Beschaeftigte.pdf?blob=publicationFile&v=1. Zugegriffen: 20. Okt. 2022
Antonelli M et al (2022) Risk of long COVID associated with delta versus omicron variants of SARS-CoV‑2. Lancet 399(10343):2263–2264
Kersten J, Baumhardt M, Hartveg P, Hoyo L, Hüll E, Imhof A, Kropf-Sanchen C, Nita N, Mörike J, Rattka M, Andreß S, Scharnbeck D, Schmidtke-Schrezenmeier G, Tadic M, Wolf A, Rottbauer W, Buckert D (2021) Long COVID: distinction between organ damage and deconditioning. J Clin Med 10:3782
Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, de Lamballerie X, Blanch H, Deleuze JF, Gouraud C, Hoertel N, Ranque B, Goldberg M, Zins M, Lemogne C, Pratiques S, Relations et Ingalits Sociales en Population Gnrale Pendant la Crise COVID-19-Serologie (SAPRIS-SERO) Study Group (2022) Association of self reported COVID-19 infection and SARS-CoV‑2 serology test results with persistent physical symptomsamong french adults during the COVID-19 pandemic. AMA Intern Med 182:19–25
Widder B, Gaidzik P (Hrsg) (2018) Neurowissenschaftliche Begutachtung, 3. Aufl. Thieme, Stuttgart
Guan WJ et al (2020) Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720
Office for National Statistics (2021) Statistical bulletin, 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/4june2021 (Erstellt: 9. Juni 2021). Zugegriffen: 20. Okt. 2022
Zhao YM et al (2020) Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2020.100463
Huang C et al (2021) 6‑month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397(10270):220–232
Zimmermann P, Pittet LF, Curtis N (2021) How common is long COVID in children and adolescents? Pediatr Infect Dis J 40(12):e482
Izquierdo-Pujol J et al (2022) Post COVID-19 condition in children and adolescents: an emerging problem. Front Pediatr 10:894204
Motiejunaite J et al (2021) Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV‑2 survivors. Eur Respir J 58(2):2101578
Naeije R, Caravita S (2021) Phenotyping long COVID. Eur Respir J. https://doi.org/10.1183/13993003.01763-2021
Rinaldo RF et al (2021) Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J 58(2):2100870
Skjørten I et al (2021) Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. Eur Respir J 58(2):2100996
Townsend L et al (2021) Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Annals ATS. https://doi.org/10.1513/AnnalsATS.202009-1175OC
Laviolette L, Laveneziana P, ERS Research Seminar Faculty (2014) Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J 43(6):1750–1762
Luger AK et al (2022) Chest CT of lung injury 1 year after COVID-19 pneumonia: the CovILD study. Radiology. https://doi.org/10.1148/radiol.211670
Yi Y et al (2020) COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci 16(10):1753
Heidbreder A et al (2021) Video-polysomnographic findings after acute COVID-19: REM sleep without atonia as sign of CNS pathology? Sleep Med 80:92–95
Yong SJ (2021) Persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci 12(4):573–580
Vitti-Ruela BV et al (2021) Possible sequelae in post-SARS-CoV-2 patients: effects on sleep and general health condition. Sleep Breath 25(2):963–964
Palmon PA, Jackson DJ, Denlinger LC (2022) COVID-19 infections and asthma. J Allergy Clin Immunol Pract 10(3):658–663
Philip KEJ et al (2022) Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respir Res 9(1):e1056
DGUV (2011) Empfehlung für die Begutachtung asbestbedingter Berufskrankheiten – Falkensteiner Empfehlung – Gesetzliche Unfallversicherung e. V. (DGUV). Referat Berufskrankheiten. www.dguv.de/publikationen
DGUV. Empfehlung für die Begutachtung von Quarzstaublungenerkrankungen (Silikosen) – Bochumer Empfehlung Update 2019. Deutsche Gesetzliche Unfallversicherung e. V. (DGUV). Referat Berufskrankheiten. www.dguv.de/publikationen Webcode: p010767
DGUV (2012) Empfehlung für die Begutachtung der Berufskrankheiten der Nummern 1315 (ohne Alveolitis), 4301 und 4302 der Anlage zur Berufskrankheiten-Verordnung (BKV) – Reichenhaller Empfehlung – Deutsche Gesetzliche Unfallversicherung (DGUV). www.dguv.de/publikationen
Tazare J et al (2021) Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform. medRxiv, S 2021.01.22.21250304
Al-Aly Z, Xie Y, Bowe B (2021) High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594(7862):259–264
Vijayakumar B, Tonkin J, Shah PL (2021) Persistent abnormalities on echocardiography post hospitalization for COVID-19. Eur Respir J. https://doi.org/10.1183/13993003.congress-2021.OA86
Puntmann VO et al (2020) Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from Coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(11):1265–1273
Kotecha T et al (2021) Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 42(19):1866–1878
Petersen EL et al (2022) Multiorgan assessment in mainly non-hospitalized individuals after SARS-CoV‑2 infection: the Hamburg City Health Study COVID programme. Eur Heart J 43(11):1124–1137
Hummel T et al (1997) „Sniffin’ sticks“: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22(1):39–52
Basta F et al (2018) Is fatigue a cause of work disability in systemic lupus erythematosus? Results from a systematic literature review. Eur Rev Med Pharmacol Sci 22(14):4589–4597
Arnaud L et al (2019) Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature. Rheumatology (Oxford) 58(6):987–996
Unger ER et al (2016) CDC grand rounds: Chronic fatigue syndrome—Advancing research and clinical education. MMWR Morb Mortal Wkly Rep 65(50–51):1434–1438
Komaroff AL, Bateman L (2020) Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med (Lausanne) 7:606824
Raman B et al (2021) Medium-term effects of SARS-CoV‑2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine 31:100683
Stussman B et al (2020) Characterization of post-exertional malaise in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol 11:1025
Stavem K et al (2021) Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph18042030
Kluger BM, Krupp LB, Enoka RM (2013) Fatigue and fatigability in neurologic illnesses: proposalfor a unified taxonomy. Neurology 80:409–416
Widder B (2021) Begutachtung und sozialmedizinische Beurteilung. In: Penner IK (Hrsg) Fatigue bei MultiplerSklerose. Hippocampus, Bad Honnef, S 131–151
Whitcroft KL, Hummel T (2019) Clinical diagnosis and current management strategies for olfactory dysfunction: a review. JAMA Otolaryngol Head Neck Surg 145:846–853
Blazhenets G, Schroeter N, Bormann T, Thurow J, Wagner D, Frings L, Weiller C, Meyer PT, Dressing A, Hosp JA (2021) Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med 62(7):910–915
AWMF-Leitlinie (Reg.Nr. 051-029) Begutachtung psychischer und psychosomatischer Störungen. https://www.awmf.org/leitlinien/detail/ll/051-029.html. Zugegriffen: 20. Okt. 2022
Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, Record C, Keh RYS, Fehmi J, Paterson RW, Bharambe V, Clayton LM, Allen C, Price O, Wall J, Kiss-Csenki A, Rathnasabapathi DP, Geraldes R, Yermakova T, King-Robson J, Zosmer M, Rajakulendran S, Sumaria S, Farmer SF, Nortley R, Marshall CR, Newman EJ, Nirmalananthan N, Kumar G, Pinto AA, Holt J, Lavin TM, Brennan KM, Zandi MS, Jayaseelan DL, Pritchard J, Hadden RDM, Manji H, Willison HJ, Rinaldi S, Carr AS, Lunn MP (2021) Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome. Brain 144:682–693
Luijten LWG, Leonhard SE, van der Eijk AA, Doets AY, Appeltshauser L, Arends S, Attarian S, Benedetti L, Briani C, Casasnovas C, Castellani F, Dardiotis E, Echaniz-Laguna A, Garssen MPJ, Harbo T, Huizinga R, Humm AM, Jellema K, van der Kooi AJ, Kuitwaard K, Kuntzer T, Kusunoki S, Lascano AM, Martinez-Hernandez E, Rinaldi S, Samijn JPA, Scheidegger O, Tsouni P, Vicino A, Visser LH, Walgaard C, Wang Y, Wirtz PW, Ripellino P, Jacobs BC, IGOS consortium (2021) Guillain-Barr syndrome after SARS-CoV‑2 infection in an international prospective cohort study. Brain 144:3392–3404
Saud A, Naveen R, Aggarwal R, Gupta L (2021) COVID-19 and myositis: what we know so far. Curr Rheumatol Rep 23:63
Meyer-Frießem CH, Gierthmühlen J, Baron R, Sommer C, Üeyler N, Enax-Krumova EK (2021) Pain during and after COVID-19 in Germany and worldwide: a narrative review of current knowledge. Pain Rep 6:893
AWMF-Leitlinie (Reg.Nr. 094-003) Ärztliche Begutachtung von Menschen mit chronischen Schmerzen. https://www.awmf.org/leitlinien/detail/ll/094-003.html. Zugegriffen: 20. Okt. 2022
Clauw DJ et al (2020) Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain 161(8):1694–1697
Derksen V et al (2021) Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2021-219859
Uygun O et al (2020) Headache characteristics in COVID-19 pandemic—A survey study. J Headache Pain 21(1):121
Lobo R, Wang M, Lobo S, Bahra A (2021) Time to retire ‘new daily persistent headache’: mode of onset of chronic migraine and tension-type headache. Cephalalgia 27:3331024211044440
Misra S, Kolappa K, Prasad M, Radhakrishnan D, Thakur KT, Solomon T, Michael BD, Winkler AS, Beghi E, Guekht A, Pardo CA, Wood GK, Hsiang-Yi Chou S, Fink EL, Schmutzhard E, Kheradmand A, Hoo FK, Kumar A, Das A, Srivastava AK, Agarwal A, Dua T, Prasad K (2021) Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis. Neurology 97:e2269–e2281
Nannoni S, de Groot R, Bell S, Markus HS (2020) Stroke in COVID-19. A systematic review and metaanalysis. Int J Stroke 16:137–149
Baeck M, Herman A (2021) COVID toes: where do we stand with the current evidence? Int J Infect Dis 102:53–55
Criado PR et al (2020) Are the cutaneous manifestations during or due to SARS-CoV‑2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res 69(8):745–756
Silva Andrade B et al (2021) Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses 13(4):700
Peiris S et al (2021) Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS ONE 16(4):e250708
Reinhart M, Metze D, Braun SA (2022) Skin manifestations of COVID-19 and after COVID-19 vaccination. Hautarzt. https://doi.org/10.1007/s00105-022-04991-w
Esen-Salman K et al (2021) Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic: Insights from Google Trends. Dermatol Ther 34(2):e14895
Isenmann S, Haehner A, Hummel T (2021) Chemosensory disorders in Covid-19: Pathomechanisms and clinical relevance. Fortschr Neurol Psychiatr 89(6):281–288
Hansen T et al (2021) Covid-fatigued? A longitudinal study of Norwegian older adults’ psychosocial well-being before and during early and later stages of the COVID-19 pandemic. Eur J Ageing. https://doi.org/10.1007/s10433-021-00648-0
Scalinci SZ, Trovato Battagliola E (2020) Conjunctivitis can be the only presenting sign and symptom of COVID-19. IDCases 20:e774
Wu P et al (2020) Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol 138(5):575–578
Danthuluri V, Grant MB (2020) Update and recommendations for ocular manifestations of COVID-19 in adults and children: a narrative review. Ophthalmol Ther 9(4):853–875
Cheema M et al (2020) Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 55(4):e125–e129
Sanjay S et al (2021) Post Coronavirus disease (COVID-19) reactivation of a quiescent unilateral anterior uveitis. Sn Compr Clin Med 3(9):1843–1847
Soni A et al (2021) Acute retinal necrosis as a presenting ophthalmic manifestation in COVID 19 recovered patients. Ocul Immunol Inflamm 29(4):722–725
Deutschen Gesellschaft für Neurologie zur Diagnostik und Therapie in der Neurologie (2021) Falkensteiner, Bochumer, Bad Reichenhaller Empfehlungen zur Begutachtung von Lungenkrankheiten. Leitlinien der Deutschen Gesellschaft für Neurologie zur Diagnostik und Therapie in der Neurologie
Philipp M (2015) Vorschlag zur diagnoseunabhängigen Ermittlung der MdE bei unfallbedingten psychischen bzw. psychosomatischen Störungen. Med Sachverstand 111:255–262
DGUV (2021) Grundlagen der Begutachtungvon Arbeitsunfällen – Erläuterungen für Sachverständige. Deutsche Gesetzliche Unfallversicherung e.V., Berlin